Policy and Advocacy

Strategic Goal One: Many more countries with effective comprehensive national hepatitis strategies in place or at least in development.  Strong patient advocacy is critical for this goal and patient group involvement with governments is crucial to the development of good strategies.  Without government commitment little progress is possible and the clearest sign of that commitment is a comprehensive national hepatitis strategy that covers everything from awareness and prevention through to treatment and care.   

Current Situation

Currently patient groups are engaged with governments in some form in about 60 countries and just a handful of countries currently have comprehensive viral hepatitis strategies.

What does WHA do?

  • WHA works with civil society, global bodies and governments to develop their national strategies.
  • We have a toolkit that civil society can use to demand change from their government. We also assist civil society groups through the process if they wish, and where possible, bring them together with appropriate stakeholders to support this change.
  • WHA collaborates on reports that represent the current situation for different countries.  We have worked with WHO on identifying the governmental position and in 2014 worked with civil society around the world to identify the gaps in that report.
  • WHA meets with governments around the world, to encourage them to develop, and support them in developing, national viral hepatitis strategies.
  • We regularly liaise with governments and promote ideas for successful interventions.
  • Every two years, we coordinate the World Hepatitis Summit with the WHO and a government. This is unique opportunity to bring patients, policymakers and public health representatives together.